Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Bria-OTS by BriaCell Therapeutics for Metastatic Breast Cancer: Likelihood of Approval
Bria-OTS is under clinical development by BriaCell Therapeutics and currently in Phase II for Metastatic Breast Cancer. According to GlobalData,...